1 nd included alopecia (29%), dysgeusia (29%), muscle cramps (29%), and anorexia (14%).

2 usea or vomiting (25%), fatigue (27.3%), and muscle cramps (4.5%).

3 old items (71%), throat discomfort (63%), or muscle cramps (42%).

4                                              Muscle cramps and hypophosphatemia were more common in t

5 without elevated CK levels, muscle weakness, muscle cramps, and persistent myalgia and CK elevations

6 presented in middle life with incapacitating muscle cramps associated with calf hypertrophy and only

7 rade 1 or 2 adverse events of loss of taste, muscle cramps, hair loss, and weight loss.

8 ncluded weight loss of 20% or more (n=6) and muscle cramps (n=2).

9 of danazol--elevated liver-enzyme levels and muscle cramps--of grade 2 or less occurred in 41% and 33

10              He also experienced progressive muscle cramps, profound sweating, bowel disturbances (di

11 is characterized by sensory paresthesias and muscle cramps that are notably exacerbated by cooling.

12    Other acute effects included diarrhea and muscle cramping, while with repeated dosing, anorexia an